Global biopharma cold chain product sales 2016-2024
This statistic displays the predicted overall trend for biopharma cold chain product sales from 2016 to 2024. In 2020, it is expected that 341 billion U.S. dollars worth of biopharma cold-chain products will be sold globally. A general increase in cold-chain products is expected, likely due to the ongoing transition to bio-based products, rigorous preconditions of life science shipments linked with the growing globalization of the pharmaceutical trade. Cold-chain products require colder temperatures throughout the storage, handling, and transportation processes to maintain product integrity.